{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:16:13Z","timestamp":1783937773992,"version":"3.55.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00496","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T08:25:22Z","timestamp":1591345522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasma Metabolite Profiles in First Episode Psychosis: Exploring Symptoms Heterogeneity\/Severity in Schizophrenia and Bipolar Disorder Cohorts"],"prefix":"10.3389","volume":"11","author":[{"given":"Helena P. G.","family":"Joaquim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana C.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda L.","family":"Talib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Dethloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio H.","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V.","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martinus","family":"van de Bilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W.","family":"Turck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.24346","article-title":"Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia","volume":"15","author":"Cunyan","year":"2018","journal-title":"Int J Med Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291714000282","article-title":"Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study","volume":"44","author":"Morgan","year":"2014","journal-title":"Psychol Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.117.201475","article-title":"Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies","volume":"211","author":"Lally","year":"2017","journal-title":"Br J Psych"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00580","article-title":"Is it possible to predict the future in first-episode psychosis","volume":"9","author":"Suvisaari","year":"2018","journal-title":"Front Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60072-6","article-title":"Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study","volume":"373","author":"Lichtenstein","year":"2009","journal-title":"Lancet"},{"key":"B6","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14cs09399","article-title":"Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design","volume":"76","author":"Burdick","year":"2015","journal-title":"J Clin Psych"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu198","article-title":"Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison with First-Episode Schizophrenia and healthy controls","volume":"41","author":"Bora","year":"2015","journal-title":"Schizophr Bull"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-1781(02)00184-1","article-title":"Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation","volume":"112","author":"Holthausen","year":"2002","journal-title":"Psych Res"},{"key":"B10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4020-9838-3_5","article-title":"Neuroendocrine markers of psychopathy","volume-title":"The handbook of neuropsychiatric biomarkers, endophenotypes and genes. Vol 3: Metabolic and peripheral biomarkers","author":"Glenn","year":"2009"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.130018","article-title":"A way forward for research on biomarkers for psychiatric disorders","volume":"38","author":"Boksa","year":"2013","journal-title":"J Psych Neurosci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.psychres.2018.12.008","article-title":"Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia","volume":"272","author":"Wang","year":"2019","journal-title":"Psych Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.11.010","article-title":"Plasma metabolites in first episode psychoses","author":"Costa","year":"2018","journal-title":"Schizophr Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.schres.2017.09.021","article-title":"A systematic review of metabolite biomarkers of schizophrenia","volume":"195","author":"Davison","year":"2017","journal-title":"Schizophr Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.08.039","article-title":"A preliminar study of bipolar disorder type I by mass spectrometry-based serum lipidomics","volume":"258","author":"Ribeiro","year":"2017","journal-title":"Psych Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101652","DOI":"10.1371\/journal.pone.0101652","article-title":"Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients","volume":"8","author":"Fukushima","year":"2014","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1224-0","article-title":"Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia","volume":"122","author":"Al-Awam","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/pr2006796","article-title":"Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action","volume":"10","author":"Xuan","year":"2011","journal-title":"J Prot Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-na\u00efve schizophrenia patients after treatment with risperidone","volume":"11","author":"Cai","year":"2012","journal-title":"J Prot Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/tp.2014.19","article-title":"A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study","volume":"4","author":"Koike","year":"2014","journal-title":"Transl Psych"},{"key":"B22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/tp.2012.76","article-title":"Schizophrenia shows a unique metabolomics signature in plasma","volume":"2","author":"He","year":"2012","journal-title":"Transl Psych"},{"key":"B23","doi-asserted-by":"publisher","first-page":"68717","DOI":"10.1371\/journal.pone.0068717","article-title":"Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics","volume":"8","author":"McEvoy","year":"2013","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol Psych"},{"key":"B25","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"B26","volume-title":"Structured clinical interview for DSM-IV-TR Axis I Disorders. Research version. Non-patient edition SCID-I\/NP New York: Biometrics Research","author":"First","year":"2002"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psych"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psych"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psych"},{"key":"B31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","article-title":"MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data","volume":"11","author":"Pluskal","year":"2010","journal-title":"BMC Bioinform"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1021\/ac202450g","article-title":"CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography\/mass spectrometry data sets","volume":"84","author":"Kuhl","year":"2012","journal-title":"Anal Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","article-title":"Centering, scaling, and transformations: improving the biological information content of metabolomics data","volume":"7","author":"Van den Berg","year":"2006","journal-title":"BMC Genomics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/ac902443k","article-title":"Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification","volume":"82","author":"Fonville","year":"2010","journal-title":"Anal Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41398-018-0294-4","article-title":"Patterns of schizophrenia symptoms: hidden structure in the PANSS questionnaire","volume":"8","author":"Lefort-Besnard","year":"2018","journal-title":"Transl Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/bib\/bbl016","article-title":"Strimmer K. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data","volume":"8","author":"Boulesteix","year":"2006","journal-title":"Brief Bioinform"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717000307","article-title":"Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum","volume":"47","author":"Van Rheenen","year":"2017","journal-title":"Psychol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.07.084","article-title":"Exploring cognitive heterogeneity in first-episode psychosis: What cluster analysis can reveal","volume":"229","author":"Reser","year":"2015","journal-title":"Psych Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12101298","article-title":"Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study","volume":"170","author":"Hill","year":"2013","journal-title":"Am J Psych"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2018.10.22.1","article-title":"Differences in Psychopathology between Offspring of Parents with Bipolar I Disorder and Those with Bipolar II Disorder: A Cross-Sectional Study","volume":"15","author":"Lee","year":"2018","journal-title":"Psych Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12075","article-title":"Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls","volume":"15","author":"Schretlen","year":"2013","journal-title":"Bip Disord"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20647","article-title":"Cognition and disability in schizophrenia: cognition-related skills deficits and decision-making challenges add to morbidity","volume":"18","author":"Harvey","year":"2019","journal-title":"World Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01414.x","article-title":"Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder","volume":"120","author":"Bora","year":"2009","journal-title":"Acta Psych Scand"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbt179","article-title":"Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum","volume":"40","author":"Tamminga","year":"2014","journal-title":"Schizophr Bull"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.12.022","article-title":"Does cognitive performance map to categorical diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder? A discriminant functions analysis","volume":"192","author":"Van Rheenen","year":"2016","journal-title":"J Affect Disord"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.12.169","article-title":"Premorbid adjustment trajectories in schizophrenia and bipolar disorder: A transdiagnostic cluster analysis","volume":"272","author":"Chan","year":"2019","journal-title":"Psych Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16121384","article-title":"A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis","volume":"175","author":"Livny","year":"2018","journal-title":"Am J Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.15121596r","article-title":"on behalf of the B-SNIP principal investigators. Challenges Facing the Identification of Neurobiologically Distinct Psychosis Subtypes: Response to Neuhaus","volume":"173","author":"Clementz","year":"2016","journal-title":"Am J Psych"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2217\/fon.12.113","article-title":"Metabolic profiling: are we enroute to better diagnostic tests for cancer","volume":"8","author":"Gu","year":"2012","journal-title":"Future Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00144","article-title":"Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry","volume":"14","author":"Liu","year":"2015","journal-title":"J Prot Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ijnp\/pyv096","article-title":"Omics-based biomarkers: Application of metabolomics in neuropsychiatric disorders","volume":"19","author":"Sethi","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2015.1117656","article-title":"Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders","volume":"18","author":"Sethi","year":"2017","journal-title":"World J Biol Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32662","article-title":"Metabolomics in patients with psychosis: a systematic review","volume":"177","author":"Li","year":"2018","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbi.2015.10.001","article-title":"Towards a blood-based diagnostic panel for bipolar disorder","volume":"52","author":"Haenisch","year":"2016","journal-title":"Brain Behav Immun"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T08:25:26Z","timestamp":1591345526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":54,"alternative-id":["10.3389\/fpsyt.2020.00496"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00496","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"article-number":"496"}}